Evidence map›Paper›PMID 21343615›Full record

ArticleBlood2011

Genome-wide analysis of target genes regulated by HoxB4 in hematopoietic stem and progenitor cells developing from embryonic stem cells.

Motohiko Oshima, Mitsuhiro Endoh, Takaho A Endo, Tetsuro Toyoda, Yaeko Nakajima-Takagi, Fumihiro Sugiyama, Haruhiko Koseki, Michael Kyba, Atsushi Iwama, Mitsujiro Osawa

Abstract read
In one paragraph

Article in Blood, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 48 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. PBX1: a TALE of two seasons-key roles during development and in cancer.Frontiers in cell and developmental biology · 2024
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Specification and function of hemogenic endothelium during embryogenesis.Cellular and molecular life sciences : CMLS · 2016
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Motohiko OshimaDepartment of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Mitsuhiro Endoh
Takaho A Endo
Tetsuro Toyoda
Yaeko Nakajima-Takagi
Fumihiro Sugiyama
Haruhiko Koseki
Michael Kyba
Atsushi Iwama
Mitsujiro Osawa
Japan Science and Technology Agency · JPChiba University · JPRIKEN Center for Integrative Medical Sciences · JPUniversity of Minnesota · USUniversity of Tsukuba · JP

Funding

Midwestern Progenitor Cell ConsortiumU01HL100407 · NHLBI · UNIVERSITY OF MINNESOTA · PI GARRY, DANIEL J., KYBA, MICHAEL · 2009 to 2015
$7.8M
Probing the Hematopoietic Hox CodeR01HL081186 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI KYBA, MICHAEL · 2007 to 2011
$2.1M
NHLBI NIH HHS R01 HL081186NHLBI NIH HHS R01HL081186
6 · The paper itself

Abstract

Forced expression of the transcription factor HoxB4 has been shown to enhance the self-renewal capacity of mouse bone marrow hematopoietic stem cells (HSCs) and confer a long-term repopulating capacity to yolk sac and embryonic stem (ES) cell-derived hematopoietic precursors. The fact that ES cell-derived precursors do not repopulate bone marrow without HoxB4 underscores an important role for HoxB4 in the maturation of ES-derived hematopoietic precursors into long-term repopulating HSCs. However, the precise molecular mechanism underlying this process is barely understood. In this study, we performed a genome-wide analysis of HoxB4 using ES cell-derived hematopoietic stem/progenitor cells. The results revealed many of the genes essential for HSC development to be direct targets of HoxB4, such as Runx1, Scl/Tal1, Gata2, and Gfi1. The expression profiling also showed that HoxB4 indirectly affects the expression of several important genes, such as Lmo2, Erg, Meis1, Pbx1, Nov, AhR, and Hemgn. HoxB4 tended to activate the transcription, but the down-regulation of a significant portion of direct targets suggested its function to be context-dependent. These findings indicate that HoxB4 reprograms a set of key regulator genes to facilitate the maturation of developing HSCs into repopulating cells. Our list of HoxB4 targets also provides novel candidate regulators for HSCs.

Indexed as

Genome-Wide Association StudyAnimalsBasic Helix-Loop-Helix ProteinsCell LineCore Binding Factor Alpha 2 SubunitDatabases, GeneticDNA-Binding ProteinsEmbryonic Stem CellsGATA2 Transcription FactorGene Expression Regulation, DevelopmentalHematopoietic Stem CellsHomeodomain ProteinsMiceOligonucleotide Array Sequence AnalysisProto-Oncogene ProteinsT-Cell Acute Lymphocytic Leukemia Protein 1Basic Helix-Loop-Helix ProteinsCore Binding Factor Alpha 2 SubunitDNA-Binding ProteinsGata2 protein, mouseGATA2 Transcription FactorGfi1 protein, mouseHomeodomain ProteinsHoxb4 protein, mouseProto-Oncogene ProteinsRunx1 protein, mouseTal1 protein, mouseT-Cell Acute Lymphocytic Leukemia Protein 1Transcription Factors

Identifiers

PMID21343615
PMCPMC3296623
OpenAlexW2118560680

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.